Finance

Beta
Lists
ONWRY:OTCMKTS
Onward Medical NV American Depositary Receipts Sponsored
$3.48
0.00%
(0.00) 1D
Jun 4, 3:21:26 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ONWRY...
Mkt. cap
196.77M
Avg. vol.
501.00
Volume
39.00
52-wk high
$7.13
52-wk low
$3.19
Shares outstanding
69.53M
No. of employees
137
Mkt. cap
196.77M
Avg. vol.
501.00
Volume
39.00
52-wk high
$7.13
52-wk low
$3.19
Shares outstanding
69.53M
No. of employees
137
News stories
From sources across the web
About Onward Medical NV American Depositary Receipts Sponsored
CEO-
Employees137
Founded2014
Headquarters-
SectorMedical device
Websiteonwd.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
592.50K
592.50K
2.11M
2.11M
Cost of goods sold
3.02M
3.02M
-2.50M
-2.50M
Cost of revenue
3.02M
3.02M
-2.50M
-2.50M
Research and development expenses
1.53M
1.53M
7.50M
7.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.04M
6.04M
7.57M
7.57M
Operating expense
7.56M
7.56M
15.07M
15.07M
Total operating expenses
10.58M
10.58M
12.57M
12.57M
Operating income
-9.99M
-9.99M
-10.46M
-10.46M
Other non operating income
-
-
-15.00K
-15.00K
EBT including unusual items
-10.50M
-10.50M
-10.24M
-10.24M
EBT excluding unusual items
-10.50M
-10.50M
-10.24M
-10.24M
Income tax expense
90.00K
90.00K
65.50K
65.50K
Effective tax rate
-0.86%
-0.86%
-0.64%
-0.64%
Other operating expenses
-
-
-
-
Net income
-10.59M
-10.59M
-10.30M
-10.30M
Net profit margin
-1,787.17%
-1,787.17%
-487.33%
-487.33%
Earnings per share
-
-
-
-
Interest and investment income
-
-
290.00K
290.00K
Interest expense
-512.50K
-512.50K
-580.00K
-580.00K
Net interest expenses
-512.50K
-512.50K
-290.00K
-290.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.75M
-9.75M
-10.44M
-10.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more